Penumbra Coil 400 4006C0308Recalls & reported problems
Penumbra, Inc. · PC400 Cplx XSft, 3x8 · Class 2 · Implant
All models of Penumbra Coil 400 (120)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI M4244006C03080), received between Sep 30, 2015 and May 11, 2021 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Detachment Of Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Detachment Of Device Component1
- Failure to Advance1
- Malposition of Device1
- Physical Resistance/Sticking1
- Premature Activation1
Patient problems
- Infarction, Cerebral1
- No Clinical Signs, Symptoms or Conditions1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 11, 2021Failure to Advance; Physical Resistance/Sticking; Failure to Advance; Physical Resistance/Sticking
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE BASILAR ARTERY USING PENUMBRA COILS 400 (PC400S) AND A PX SLIM DELIVERY MICROCATHETER (PX SLIM). DURING THE PROCEDURE, THE THIRD COIL, A PC400, WAS UNABLE TO BE ADVANCED INTO THE PX SLIM AND RESISTANCE WAS NOTED. THEREFORE, THE PC400 WAS REMOVED. THE PROCEDURE WAS COMPLETED USING A NEW PC400 AND THE SAME PX SLIM. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11806691 ↗MalfunctionJun 7, 2016Detachment Of Device Component; Premature Activation; Malposition of Device; Detachment Of Device Component; Premature Activation; Malposition of Device
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE DISTAL VERTEBRAL ARTERY (DVA) USING PENUMBRA COIL 400 COILS (PC400 COILS). PRIOR TO PLACING COILS INTO THE PATIENT, THE PHYSICIAN IMPLANTED THREE FLOW DIVERTING STENTS FROM ANOTHER MANUFACTURER VIA THE RIGHT VERTEBRAL ARTERY. THE ANEURYSM SAC WAS THEN ACCESSED VIA THE LEFT VERTEBRAL ARTERY FOR COIL EMBOLIZATION. WHILE ATTEMPTING TO ADVANCE AN INITIAL PC400 COIL INTO THE PX SLIM DELIVERY MICROCATHETER (PX SLIM), THE PHYSICIAN HAD DIFFICULTY ADVANCING THE COIL OUT OF ITS INTRODUCER SHEATH. UPON FURTHER MANIPULATION, THE PHYSICIAN WAS STILL UNABLE TO ADVANCE THE PC400 COIL AND THEREFORE, THE COIL WAS REMOVED. THE PROCEDURE CONTINUED USING ADDITIONAL PC400 COILS. WHILE ATTEMPTING TO PLACE THE LAST PC400 COIL INTO THE DVA, THE PHYSICIAN RETRACTED THE COIL AND SUBSEQUENTLY, THE COIL UNINTENTIONALLY DETACHED. THE PC400 COIL EXTENDED DOWN FROM THE VERTEBRAL/BASILAR JUNCTION APPROXIMATELY SIX CENTIMETERS TO THE PROXIMAL VERTEBRAL ARTERY. THE PROCEDURE WAS COMPLETED AT THIS POINT WITH NO IMMEDIATE ADVERSE EFFECTS NOTED. THE PATIENT HAD A FOLLOW UP ANGIOGRAM TWO DAYS POST PROCEDURE WHICH REVEALED THAT THE PC400 COIL WAS STILL IN
Patient problems: No Consequences Or Impact To Patient
MAUDE report 5704005 ↗InjurySep 30, 2015Adverse Event Without Identified Device or Use Problem
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION IN THE ANTERIOR CEREBRAL ARTERY (ACA)-ANTERIOR COMMUNICATING ARTERY USING PENUMBRA COIL 400 COILS (PC400 COILS). DURING THE PROCEDURE, THIRTEEN PC400 COILS WERE SUCCESSFULLY DEPLOYED AND DETACHED INTO THE ANEURYSM WITH NO COMPLICATIONS. APPROXIMATELY 3 MONTHS POST-PROCEDURE, THE PATIENT EXPERIENCED A SEVERE ISCHEMIC STROKE IN THE LEFT ANTERIOR CEREBRAL ARTERY. CORONARY COMPUTED TOMOGRAPHY ANGIOGRAM (CTA), MAGNETIC RESONANCE IMAGING (MRI), ELECTROENCEPHALOGRAM (EEG), TRANSTHORACIC ECHOCARDIOGRAM (TTE) WERE PERFORMED AND THE PATIENT WAS TREATED WITH SIMVASTATIN. THE REPORTED ISCHEMIC STROKE RESOLVED ON (B)(6) 2013.
Patient problems: Infarction, Cerebral
MAUDE report 5114238 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page